It is a trading private limited company based in New Delhi, Delhi, India, established in 1991.
1991 | New Delhi, Delhi, India | ActiveDnsco Pharma Private Limited, a active private limited company, was established on 16 July 1991 in New Delhi, Delhi, India. Engaging in wholesale within the trading sector, it holds CIN: U74899DL1991PTC044992. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Kanav Nangia (Director), Neelu Nangia (Director), Sanjeev Nangia (Director). Past directors included Kanav Nangia, Shakuntla Nangia, Sakshi Gupta. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H-9 Lajpat Nagar Ii, New Delhi, Delhi, 110024.
U74899DL1991PTC044992
044992
16 July 1991
₹0.50 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Dnsco Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kanav Nangia | Director | 01 May 2013 | Current |
| Neelu Nangia | Director | 07 Apr 1993 | Current |
| Sanjeev Nangia | Director | 01 Oct 1999 | Current |
| Sakshi Gupta | Director | 01 Aug 2023 | Current |
| Naiyaa Arora | Director | 01 Jun 2021 | Current |
| Gunpreet Kaur Sodhi | Director | 01 Jun 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Director | 01 Apr 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Nov 2021 | Past |
| Pramod Abcsdd | Director | 31 Mar 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dnsco Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 55.86% increase. The company also saw a substantial improvement in profitability, with a 77.26% increase in profit. The company's net worth Soared by an impressive increase of 33.58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Dnsco Pharma had a promoter holding of 97.80% and a public holding of 2.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Dnsco Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dnsco Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dnsco Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sanjay Nangia was appointed as a Additional Director was appointed as a Additional Director on 18 Apr 2025 & has been associated with this company since 7 months 22 days . was recorded as a recent event.
Progress on Sabina Nangia was appointed as a Additional Director was appointed as a Additional Director on 18 Apr 2025 & has been associated with this company since 7 months 22 days . was documented.
The activity Karan Nangia was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2025 & has been associated with this company since 8 months 8 days . was completed.
Rohan Nangia was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2025 & has been associated with this company since 8 months 8 days . was recorded as a recent event.
Progress on Anjum Nangia was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2025 & has been associated with this company since 8 months 8 days . was documented.
Progress on Dnsco Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The CIN of Dnsco Pharma Private Limited is U74899DL1991PTC044992.
Dnsco Pharma Private Limited is headquartered at H-9 Lajpat Nagar Ii, New Delhi, Delhi, 110024.
Dnsco Pharma Private Limited was incorporated on 16 July 1991.
The current directors of Dnsco Pharma Private Limited are
The primary industry of Dnsco Pharma Private Limited is Trading.
Dnsco Pharma Private Limited is unlisted.
The authorized capital of Dnsco Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Dnsco Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX